Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amplifon S.p.A. stock logo
AMFPF
Amplifon
$18.33
+5.0%
$19.87
$16.97
$29.33
$4.13B0.3514 shs160 shs
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
$73.74
-4.2%
$75.63
$46.36
$83.02
$14.86B0.561,083 shs442 shs
Icon Plc stock logo
ICLR
Icon
$165.44
-2.1%
$166.87
$125.10
$310.54
$13.64B1.2948,250 shs1.47 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$476.69
-1.8%
$422.55
$250.05
$501.30
$13.64B1.44314,499 shs342,678 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amplifon S.p.A. stock logo
AMFPF
Amplifon
0.00%+4.98%+4.98%-23.14%-42.50%
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
-4.24%-0.85%-2.76%+2.41%+31.61%
Icon Plc stock logo
ICLR
Icon
-2.07%-8.09%+3.59%+12.48%-41.02%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
-1.83%-0.94%+5.99%+56.81%+45.42%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amplifon S.p.A. stock logo
AMFPF
Amplifon
$18.33
+5.0%
$19.87
$16.97
$29.33
$4.13B0.3514 shs160 shs
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
$73.74
-4.2%
$75.63
$46.36
$83.02
$14.86B0.561,083 shs442 shs
Icon Plc stock logo
ICLR
Icon
$165.44
-2.1%
$166.87
$125.10
$310.54
$13.64B1.2948,250 shs1.47 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$476.69
-1.8%
$422.55
$250.05
$501.30
$13.64B1.44314,499 shs342,678 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amplifon S.p.A. stock logo
AMFPF
Amplifon
0.00%+4.98%+4.98%-23.14%-42.50%
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
-4.24%-0.85%-2.76%+2.41%+31.61%
Icon Plc stock logo
ICLR
Icon
-2.07%-8.09%+3.59%+12.48%-41.02%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
-1.83%-0.94%+5.99%+56.81%+45.42%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amplifon S.p.A. stock logo
AMFPF
Amplifon
2.50
Moderate BuyN/AN/A
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
2.33
HoldN/AN/A
Icon Plc stock logo
ICLR
Icon
2.79
Moderate Buy$216.6730.96% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
1.94
Reduce$422.27-11.42% Downside

Current Analyst Ratings Breakdown

Latest AMFPF, ERFSF, ICLR, and MEDP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/9/2025
Icon Plc stock logo
ICLR
Icon
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyHold$220.00 ➝ $175.00
9/9/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$400.00 ➝ $450.00
9/3/2025
Icon Plc stock logo
ICLR
Icon
Rothschild Redb
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
9/3/2025
Icon Plc stock logo
ICLR
Icon
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutralBuy$184.00 ➝ $236.00
9/3/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Rothschild Redb
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
9/3/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyNeutral$342.00 ➝ $474.00
9/2/2025
Icon Plc stock logo
ICLR
Icon
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$222.00 ➝ $224.00
8/21/2025
Icon Plc stock logo
ICLR
Icon
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyNeutral$225.00 ➝ $200.00
7/29/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutralSell$300.00 ➝ $305.00
7/25/2025
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
7/25/2025
Icon Plc stock logo
ICLR
Icon
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$173.00 ➝ $225.00
(Data available from 9/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amplifon S.p.A. stock logo
AMFPF
Amplifon
$2.61B1.59$2.19 per share8.38$5.52 per share3.32
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
$7.52B1.89$6.90 per share10.69$30.19 per share2.44
Icon Plc stock logo
ICLR
Icon
$8.28B1.61$19.63 per share8.43$117.92 per share1.40
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.11B6.35$13.69 per share34.81$26.56 per share17.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amplifon S.p.A. stock logo
AMFPF
Amplifon
$157.31M$0.6130.05N/A5.20%13.70%3.85%10/29/2025 (Estimated)
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
$439.77MN/A0.0018.76N/AN/AN/AN/AN/A
Icon Plc stock logo
ICLR
Icon
$791.47M$9.7217.0210.822.509.82%10.95%6.23%10/22/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.4535.4434.903.0618.74%67.66%21.86%10/20/2025 (Estimated)

Latest AMFPF, ERFSF, ICLR, and MEDP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Amplifon S.p.A. stock logo
AMFPF
Amplifon
$0.3406$0.25-$0.0906$0.18$625.73 million$698.20 million
7/23/2025Q2 2025
Icon Plc stock logo
ICLR
Icon
$3.18$3.26+$0.08$2.30$1.98 billion$2.02 billion
7/21/2025Q2 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.00$3.10+$0.10$3.10$537.70 million$603.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amplifon S.p.A. stock logo
AMFPF
Amplifon
N/AN/AN/AN/AN/A
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
N/AN/AN/AN/AN/A
Icon Plc stock logo
ICLR
Icon
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amplifon S.p.A. stock logo
AMFPF
Amplifon
1.03
0.61
0.53
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
0.77
1.26
1.19
Icon Plc stock logo
ICLR
Icon
0.35
1.29
1.29
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.43
0.43

Institutional Ownership

CompanyInstitutional Ownership
Amplifon S.p.A. stock logo
AMFPF
Amplifon
N/A
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
N/A
Icon Plc stock logo
ICLR
Icon
95.61%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%

Insider Ownership

CompanyInsider Ownership
Amplifon S.p.A. stock logo
AMFPF
Amplifon
N/A
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
N/A
Icon Plc stock logo
ICLR
Icon
44.00%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amplifon S.p.A. stock logo
AMFPF
Amplifon
15,070225.50 millionN/ANot Optionable
EUROFINS SCIENT stock logo
ERFSF
EUROFINS SCIENT
62,696192.98 millionN/ANot Optionable
Icon Plc stock logo
ICLR
Icon
41,90080.76 million45.22 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,90028.09 million22.39 millionOptionable

Recent News About These Companies

Redburn Atlantic downgrades Medpace Holdings (MEDP) to a Hold
Medpace (NASDAQ:MEDP) CEO Sells $17,225,676.40 in Stock
Medpace Holdings, Inc. (MEDP): A Bull Case Theory
Medpace (NASDAQ:MEDP) Shares Unloaded Rep. David Taylor

New MarketBeat Followers Over Time

Media Sentiment Over Time

Amplifon stock logo

Amplifon OTCMKTS:AMFPF

$18.33 +0.87 (+4.98%)
As of 09/9/2025 02:09 PM Eastern

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.

EUROFINS SCIENT stock logo

EUROFINS SCIENT OTCMKTS:ERFSF

$73.74 -3.26 (-4.24%)
As of 09/10/2025 02:12 PM Eastern

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Icon stock logo

Icon NASDAQ:ICLR

$165.44 -3.50 (-2.07%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$165.60 +0.16 (+0.09%)
As of 09/10/2025 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Medpace stock logo

Medpace NASDAQ:MEDP

$476.69 -8.90 (-1.83%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$475.05 -1.64 (-0.34%)
As of 09/10/2025 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.